PHENYTOIN BINDING TO PARTIALLY PURIFIED ALBUMIN IN RENAL-DISEASE

[1] ANDREASEN F, 1974, ACTA PHARMACOL TOXIC, V34, P234

[2] ANTON AH, 1971, ACTA PHARMACOL TOX, V29, P134

[3] BOOBIS SW, 1977, CLIN PHARMACOL THER, V22, P147

[4] CRAIG WA, 1976, J LAB CLIN MED, V87, P637

[5] GEBOTT MD, 1975, MICROZONE ELECTROPHO

[6] EFFECT OF ENDOGENOUS COMPOUNDS, ISOLATED FROM SERA OF UREMIC PATIENTS, ON CHLORAMPHENICOL BINDING TO PROTEINS [J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (19) : 2923 - 2928

[7] GUGLER R, 1976, Clinical Pharmacokinetics, V1, P25, DOI 10.2165/00003088-197601010-00003

[8] HOOPER WD, 1974, CLIN PHARMACOL THER, V15, P276

[9] LECOMTE M, 1979, EUROPEAN J DRUG META, V1, P23

[10] PLASMA-PROTEIN BINDING INTERACTION BETWEEN PHENYTOIN AND VALPROIC ACID INVITRO [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (06) : 487 - 492

[1] ANDREASEN F, 1974, ACTA PHARMACOL TOXIC, V34, P234

[2] ANTON AH, 1971, ACTA PHARMACOL TOX, V29, P134

[3] BOOBIS SW, 1977, CLIN PHARMACOL THER, V22, P147

[4] CRAIG WA, 1976, J LAB CLIN MED, V87, P637

[5] GEBOTT MD, 1975, MICROZONE ELECTROPHO

[6] EFFECT OF ENDOGENOUS COMPOUNDS, ISOLATED FROM SERA OF UREMIC PATIENTS, ON CHLORAMPHENICOL BINDING TO PROTEINS [J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (19) : 2923 - 2928

[7] GUGLER R, 1976, Clinical Pharmacokinetics, V1, P25, DOI 10.2165/00003088-197601010-00003

[8] HOOPER WD, 1974, CLIN PHARMACOL THER, V15, P276

[9] LECOMTE M, 1979, EUROPEAN J DRUG META, V1, P23

[10] PLASMA-PROTEIN BINDING INTERACTION BETWEEN PHENYTOIN AND VALPROIC ACID INVITRO [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (06) : 487 - 492